🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 68232V801 (prev. 68232V405 )
- Market Cap
- Micro Cap
- IPO
- 7/24/2013 · $15.00/share
- Previous Symbol
- ONTX (changed 4/3/2024)
- Previous Name
- Onconova Therapeutics, Inc.
Business: Traws Pharma, Inc.. is a clinical stage biopharmaceutical company developing oral small molecule therapies for the treatment of respiratory viral diseases and cancer. The Company is committed to delivering novel compounds for unmet medical needs using state-of-the-art drug development technology. With a focus on product safety and a commitment to patients in need or that are specifically vulnerable, we aim to build solutions for important medical challenges and alleviate the burden of viral infections and cancer.
Notes: Sept. 25, 2018 -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) today announced a one-for-fifteen reverse stock split of its common stock, effective September 25, 2018. Beginning on September 26, 2018, Onconova common stock will continue to trade on the Nasdaq Capital Market under the trading symbol “ONTX.” The new CUSIP number for the common stock following the reverse stock split is 68232V 405. ____________ June 1, 2016 -- Onconova Therapeutics, Inc. (ONTX) will effect a one-for-ten (1-10) reverse split of its common stock and the CUSIP number will change to 68232V306.
Company Contact
- CEO
- Iain Dukes
- CFO
- Charles Parker
- Headquarters
- 12 Penns Trail, Newtown, PA 18940
- Phone
- 267-759-3680
- Investor Relations
- Bruce Mackle, LifeSci Advisors, LLC · 646-889-1200 · bmackle@lifesciadvisors.com